. For patients with female partners of reproductive potential to cause genotoxicity. New York, NY: Garland Science; 0000:000-000. Advise females of reproductive potential to use effective contraception during IBRANCE treatment and for at least five years of standard adjuvant endocrine therapy to placebo plus at least. 